合作者(4083)TOP 5
  • Thomas,GN
  • Critchley,JAJH
  • Hu,Miao
  • Chan,JCN
  • Chan,Paul
關 鍵 字
發文可能採用名字
  • Brian Tomlinson
  • 湯寧信
  • Tomlinson, Brian
  • Tomlinson, B
  • 汤宁信
  • Brian TOMLINSON
  • Tomlinson, B.
  • Tomlinson B
  • Tomlinson B.
  • Tomlinson Brian
  • Tomlinson ,B.
  • Tomlinson B rian
  • Brian, Tomlinson
  • TOMLINSON, B

湯寧信

醫學院(FMD)

ORCID: 0000-0001-6717-5444

ResearcherID: AAD-9404-2019; P-5365-2015

成果: 792 件 | 合作者:4083 

WOS核心合集引用:18375 | H Index:64 | WOS收錄:620

CNKI收錄:15 | SCOPUS收錄:509

論文: 792

論文: 792 篇 上傳 編輯 糾錯 可能是湯寧信的文章 匯出

1.Comparing rosuvastatin and atorvastatin on cardiovascular and kidney outcomes in patients with diabetes across chronic kidney disease stages: an emulated target trial in China

Huang, YT, Yang, AM,     More...

ECLINICALMEDICINE[2589-5370], Published 2026, Volume 91,

收錄情况: WOS

WOS核心合集引用: 0  2024影響因子:  10.0 

2.Targeting APOC3 with Olezarsen in Moderate Hypertriglyceridemia.

Tomlinson, Brian

New England Journal of Medicine[0028-4793], Published 2026, Volume 394, Issue 1, Pages 99

收錄情况: SCOPUS

2024影響因子:  78.5 

3.Targeting KAT8 alleviates vascular senescence by modulating the INHBA/TGF-β pathway

Lin, Zhongxiao, Xion     More...

Molecular Therapy[1525-0016], Published 2026,

收錄情况: SCOPUS

2024影響因子:  12.0 

4.An up-to-date review of emerging biologic therapies for hypercholesterolemia

Tomlinson, B

EXPERT OPINION ON BIOLOGICAL THERAPY[1471-2598], Published 2025, Volume 25, Issue 1, Pages 69-78

收錄情况: WOS SCOPUS

WOS核心合集引用: 2  2024影響因子:  4.0 

5.Exploring emerging pharmacotherapies for type 2 diabetes patients with hypertriglyceridemia

Tomlinson, B, Chan,     More...

EXPERT OPINION ON PHARMACOTHERAPY[1465-6566], Published 2025, Volume 26, Issue 3, Pages 279-289

收錄情况: WOS SCOPUS

WOS核心合集引用: 1  2024影響因子:  2.7 

6.Cardiomyocyte Foxp1-Specific Deletion Promotes Post-injury Heart Regeneration via Targeting Usp20-HIF1α-Hand1 Signaling Pathway

Wang, YF, Wang, XY,     More...

ADVANCED SCIENCE[2198-3844], Published 2025, Volume 12, Issue 12,

收錄情况: WOS SCOPUS

WOS核心合集引用: 7  2024影響因子:  14.1 

7.Overweight, obesity, and cardiovascular disease in heterozygous familial hypercholesterolaemia: the EAS FH Studies Collaboration registry

Elshorbagy, A, Valle     More...

EUROPEAN HEART JOURNAL[0195-668X], Published 2025, Volume 46, Issue 12, Pages 1127-1140

收錄情况: WOS SCOPUS

WOS核心合集引用: 11  2024影響因子:  35.7 

8.Systematic review of lipoprotein(a) levels in chinese subjects with and without atherosclerotic cardiovascular disease

Tomlinson, B, Lao, U     More...

ATHEROSCLEROSIS[0021-9150], Published 2025, Volume 407,

收錄情况: WOS

WOS核心合集引用: 0  2024影響因子:  5.7 

9.Metformin in polycystic ovary syndrome: unraveling multi-stage therapeutic mechanisms from puberty to long-term health outcomes

Zeng, WW, Luo, YN, O     More...

FRONTIERS IN PHARMACOLOGY[1663-9812], Published 2025, Volume 16,

收錄情况: WOS SCOPUS

WOS核心合集引用: 1  2024影響因子:  4.8 

10.Statin-Related Transaminitis-Is It Necessary to Stop Statins?

Tomlinson, B, Zeng,     More...

CARDIOVASCULAR DRUGS AND THERAPY[0920-3206], Published 2025,

收錄情况: WOS SCOPUS

WOS核心合集引用: 0  2024影響因子:  3.1 

本系統需要使用 Internet Explorer 9.0 以上Firefox || Chrome瀏覽器

Copyright © 2018 澳門科技大學學者庫